Member Info for MysticMike

Just over a year ago (30th July) Tim became CEO and the share price was just over 8p and he promised this "With my appointment as CEO, leading ImmuPharma through this next significant period, I am determined, working with the excellent team around me, in building shareholder value by progressing the development and commercialisation of all the key assets in our portfolio." And the SP has been diluted and sank quicker than the Titanic it is time for Tim McC to step down his communication skills have always been poor and he always over promises and under delivers.

End

Come on Tim give us an update from an IMM stance of what has been requested from the FDA our share price is a disaster and you are not looking after us!

Tim is only worried about himself he has never proved that he cares about shareholders, we should have had an update by now it must be bad news.

Thanks Ontarget, catching up on chats been busy will check the link out

Hi can anyone give me an update on Juvenescence as we are coming up to the 2 year announcement anniversary, are they about to market our product? Will we see royalties start to come through?

Nolupus, Tim has never worried about his credibility and has never been trustworthy if IMM had someone different has a Chairman and CEO the SP would be double what is now possibly a little higher. I for one would be invested more.

As I’ve said many times we need to get our money back from Tim’s other business Incartha

Tim Mc when will we see this promised return on our Incartha investment no update for such a long time now. No need for a placement.
Does anyone have any update?

Tim needs 5o get our money back from Incartha

If the SP rises like it did in 2018 on the last P3 then we should >15p by close today and another jump tomorrow to >20p
Fingers crossed there are larger buyers who listen to Avion and take the plunge.

At this week's AGM shareholders need to demand a full detailed timeline for the P3 trial,
1. When will the selection process start?
2. When will the drug start to be administered and for how long?
3. Are there any review and update points
4. At what date do they plan to stop and pass the results on to the FDA?
5. When do they aim to get full FDA approval if successful?
With both Imm and Avions experience todate my estimate is mid to late 2025

Agreed terrible RNS but typically Tim McC has no future timelines of when we can expect FDA decision. Very annoyed yet again I will not learn.

Tim McC can you please do what you promised in your RNS dated the 12th August 2021, I know its nearly a year ago but you to keep promises rather thank not keeping them. We want to trust you but you are not giving us a lot of coms or confidence in the way you are running IMM. We could also do with seeing a return on the money invested in Incartha as promised by you last year and the year before that it sound too familiar. Come on Tim wake up.

The number of shares have increased significantly since then but 50p to £1 is very reasonable expectation.

Thorndon I do hope so but in Sept 2016 we were at the same place just starting Lupuzor stage III and look where we have come much much more dilution and a share price that is down from around 40p to now 6p. I started investing in early 2018 and have had to keep investing to bring down my average but I'm still showing a loss so a party would be great but I've been let down too many times by Imm and Tim McC but I should feel good that he's taken a good salary for doing very little but I don't. I'm just hoping history does not repeat itself because last time there was no updates we knew what happened the sp crashed. Imm need to go on a communication course they could advise on whether the PK Study has finished and if the results have been forwarded on to the FDA they don't even have to tell us whether they are pleased with them or not.

PK Study update required, timeline so far FDA agreed to PK Study December 2020 and confirmed in writing August 2021 and Tim and Imm started trial Feb 2022 and then promised results by end of Q1 2022. Can you please keep to your promises I know we should be used to you always breaking them and being so so slow it's like watching a sloth in the zoo.
Update please even if it is an apology for being late yet again and a new estimated date for the PK Study results.

Does anyone know when Poland will be completed?

Easyp I'm disappointed by this rns we were given the go ahead in Feb 2021 and it has taken a year to get it started, how long will it take for phase 3 to start and finish and then go to market, on what Imm and Tim has achieved so far my estimate would be Feb 2026.
Come on Avion pull your finger out push Imm a bit more

Michael2021 it tells us that investors don't trust Tim McC and the lack of delivering anything e.g. PK Study, Avion may be to blame who knows but IMM will never tell us unless there is a change at the top new CEO and Chairman. I did not expect it to go below 5p but I'm worried now as I've invested a large amount of my pension savings. It is going to be a gloomy Xmas when if the PK Study had started in Sept like it was promised we would now be talking about phase 3 starting . Has anyone got anything positive to help lift the gloom

Tim open your eyes please the last two RNS should have sparked some upward movement in the SP but investors are worried how big a line you are wanting to draw under the past, we need a full update on financials, when will incanthera be able to pay back our investment and what is the plan to fund the business to the end of 2023 as we can all see there is not enough money in the company. Let's see more of the promised better comms and honesty.